Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA
Read MoreMedis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA
Read MoreMedis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA
Read MoreMedis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA
Read MoreTerumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, announced today that they have entered into a strategic partnership, in the United States, to enhance cardiovascular care through the utilization of both ePRISM – Terumo’s proprietary clinical decision support platform – and Medis’ Quantitative Flow Ratio (QFR) technology, a non-invasive software solution designed to assess angiography-derived coronary physiology.
Read More